ANALYSIS OF THYMIC STROMAL CELL SUBPOPULATIONS GROWN IN-VITRO ON EXTRACELLULAR-MATRIX IN DEFINED MEDIUM .5. PROLIFERATION REGULATING ACTIVITIES IN SUPERNATANTS OF HUMAN THYMIC EPITHELIAL-CELL CULTURES
A. Meilin et al., ANALYSIS OF THYMIC STROMAL CELL SUBPOPULATIONS GROWN IN-VITRO ON EXTRACELLULAR-MATRIX IN DEFINED MEDIUM .5. PROLIFERATION REGULATING ACTIVITIES IN SUPERNATANTS OF HUMAN THYMIC EPITHELIAL-CELL CULTURES, International journal of immunopharmacology, 19(1), 1997, pp. 39-47
In previous reports in this series, we described the growth conditions
, morphology and supernatant activities of human thymic epithelial cel
l cultures. The human thymic epithelial cell supernatant (HTES) contai
ned IL-6, G-CSF and M-CSF activities and exhibited a strong enhancing
effect on thymocyte proliferative response to mitogens, which was iden
tified as IL-6 related. The responding thymocyte population was appare
ntly identified as PNA, mature T cells. Tn order to simplify further a
nalysis of HTES activities, we selected to use a well-defined mature m
urine T cell clone which has a Th2 phenotype (8-5 clone). HTES induced
8-5 cell proliferation without the presence of antigen, antigen prese
nting cells (APC) or mitogens. This enhancing effect of HTES was compl
etely blocked with anti hIL-6 antibody but could not be reproduced by
rhIL-6 alone. Hence, IL-6 is a necessary but insufficient factor in me
diating this effect. HTES induced proliferation was accompanied by end
ogenous IL-4 secretion from 8-5 cells. Furthermore, the proliferation
was blocked by anti mIL-4 antibody, implicating IL-4 as an autocrine g
rowth factor in this system. HTES increased also the expression of IL-
2 receptor. In addition, rhIL-2 and rmIL-4 each had a synergistic effe
ct on the proliferative response of 8-5 cells to HTES. A similar syner
gistic activity was demonstrated when rhIL-6 was used instead of HTES,
suggesting that IL-6 regulates some of HTES activities. Our findings
indicate that HTES activities, of which IL-6 is only part, are mediate
d via the induction of autocrine growth factors and by the regulation
of T cell growth factor receptor expression. (C) 1997 International So
ciety for Immunopharmacology.